CRNX vs HPE · rev $35.9M vs P/E 20, rev $32.19B
Crinetics Pharmaceuticals Inc (CRNX) versus Hewlett Packard Enterprise Co (HPE) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
CRNX currently screens at market cap $2.76B. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Not investment advice. Open the CRNX and HPE stock pages for the full models.
Not investment advice.